IRIS Accounts Production v25.4.0.155 12547483 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125474832024-03-31125474832025-03-31125474832024-04-012025-03-31125474832023-03-31125474832023-04-012024-03-31125474832024-03-3112547483ns15:EnglandWales2024-04-012025-03-3112547483ns14:PoundSterling2024-04-012025-03-3112547483ns10:Director12024-04-012025-03-3112547483ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3112547483ns10:SmallEntities2024-04-012025-03-3112547483ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3112547483ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3112547483ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3112547483ns10:FullAccounts2024-04-012025-03-3112547483ns10:Director22024-04-012025-03-3112547483ns10:RegisteredOffice2024-04-012025-03-3112547483ns5:CurrentFinancialInstruments2025-03-3112547483ns5:CurrentFinancialInstruments2024-03-3112547483ns5:ShareCapital2025-03-3112547483ns5:ShareCapital2024-03-3112547483ns5:SharePremium2025-03-3112547483ns5:SharePremium2024-03-3112547483ns5:RetainedEarningsAccumulatedLosses2025-03-3112547483ns5:RetainedEarningsAccumulatedLosses2024-03-3112547483ns5:PlantMachinery2024-04-012025-03-3112547483ns5:PlantMachinery2024-03-3112547483ns5:PlantMachinery2025-03-3112547483ns5:PlantMachinery2024-03-3112547483ns5:CostValuation2024-03-3112547483ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3112547483ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31125474831ns10:Director12024-03-31125474831ns10:Director12023-03-31125474831ns10:Director12024-04-012025-03-31125474831ns10:Director12023-04-012024-03-31125474831ns10:Director12025-03-31125474831ns10:Director12024-03-31
REGISTERED NUMBER: 12547483 (England and Wales)















Sequential Skin Ltd

Unaudited Financial Statements for the Year Ended 31 March 2025






Sequential Skin Ltd (Registered number: 12547483)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Sequential Skin Ltd

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Dr A Dashi
Dr J O P Worsley





REGISTERED OFFICE: 85 Great Portland Street
London
W1W 7LT





REGISTERED NUMBER: 12547483 (England and Wales)





ACCOUNTANTS: Hughes Waddell
The White House
2 Meadrow
Godalming
Surrey
GU7 3HN

Sequential Skin Ltd (Registered number: 12547483)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 80,562 85,619
Investments 5 1 1
80,563 85,620

CURRENT ASSETS
Debtors 6 609,076 222,540
Cash at bank and in hand 731,563 249,155
1,340,639 471,695
CREDITORS
Amounts falling due within one year 7 165,662 18,972
NET CURRENT ASSETS 1,174,977 452,723
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,255,540

538,343

CAPITAL AND RESERVES
Called up share capital 2,414,728 1,759,799
Share premium 74,949 74,949
Retained earnings (1,234,137 ) (1,296,405 )
1,255,540 538,343

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 December 2025 and were signed on its behalf by:



Dr J O P Worsley - Director


Sequential Skin Ltd (Registered number: 12547483)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Sequential Skin Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised when the company obtains the right to consideration.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on cost

Investments in subsidiaries
Investments in subsidiaries are stated at cost less accumulated impairment losses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 5 ) .

Sequential Skin Ltd (Registered number: 12547483)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2024 160,592
Additions 33,828
At 31 March 2025 194,420
DEPRECIATION
At 1 April 2024 74,973
Charge for year 38,885
At 31 March 2025 113,858
NET BOOK VALUE
At 31 March 2025 80,562
At 31 March 2024 85,619

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2024
and 31 March 2025 1
NET BOOK VALUE
At 31 March 2025 1
At 31 March 2024 1

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 417,465 131,536
Other debtors 191,611 91,004
609,076 222,540

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade creditors 53,283 -
Taxation and social security 9,359 6,920
Other creditors 103,020 12,052
165,662 18,972

Sequential Skin Ltd (Registered number: 12547483)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Dr J O P Worsley
Balance outstanding at start of year 447 -
Amounts advanced 2,076 447
Amounts repaid (1,659 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 864 447

This amount was repaid within 9 months of the year end.